We recently celebrated our 100th issue and 10 years of publishing content about drug development and manufacturing. When we first started out, vaccines, although crucial, weren’t considered a “hot” topic by the industry. The times have changed. The COVID-19 pandemic has helped to accelerate vaccine science and inspire greater innovation in all aspects of vaccine development. Take a look at some of our top content in this field.
Lessons Learned: Leveraging Pandemic Pandemonium for a Better Future
How can we apply accelerated mRNA vaccine development learnings to Industry 4.0?
Medicine Makers of History: Salk and Sabin
How two rival projects relate to a modern disease landscape threatened by climate change and low vaccination rates
The Greatest Medicine Making Challenge
How do we vaccinate billions of people? “Nobody wins the race until everyone wins.”
Fantastic Vaccines and Where to Find Them: Lessons Learned with Nima Farzan
The field of specialty vaccines can feel underloved, but with growing interest from public health groups, previously under-served diseases may soon have hope.
Ode to the Microbe
Understanding the role of microbial fermentation in the supply of the DNA template, RNA polymerase, and enzymes used in purification of mRNA vaccines
Hitting a Moving Target
Flu is a protean creature. How can we pin it down?
A Day in Egg City: Seven Things I Learned on a Visit to Britain’s Largest Flu Vaccine Factory
From hemispheric analysis to hatchery logistics, there’s a lot more to vaccine production than you might suspect
A Tale of Two Continents
How discussions between the European and African Unions have culminated in a new deal for African vaccine production
mRNA: The New Kid on the Vaccine Block
Exploring the manufacturing challenges of mRNA vaccines
The Right to Decide
Let’s not ride roughshod over patient autonomy when it comes to national vaccination campaigns
Newsletters
Receive the latest analytical science news, personalities, education, and career development – weekly to your inbox.
